Sobre la Empresa
- Nombre legal: YANGZHOU QINYUAN PHARMATECH CO., LTD
- País de registro: China
- Dirección: No.168, Zhicheng Road, Industrial District, Maji Town, Yizheng City, Jiangsu, China • Jiangsu
- Año de fundación: 2015
Descripción:
Yangzhou Qinyuan Pharmatech Co., Ltd, established in 2015, is a manufacturer specializing in active pharmaceutical ingredient R&D and sales, customized synthesis medicine, impurity reference substance manufacturing, technology transfer, and pharmaceutical intermediate development. Its main products span organic compounds, pharmaceutical intermediates, and APIs, supported by R&D engineers with roughly 20 years of experience working in well-equipped laboratories. Offering CMO and CDMO contract manufacturing and accepting a wide range of payment methods, the company serves customers across North and South America, Europe, Asia, the Middle East, and Africa, competing on brand recognition, international approvals, experienced R&D staff, production capacity, and a broad product line, while emphasizing consistent quality, joint product development, and long-term customer partnerships.
Actividades Comerciales
Ingredientes Farmacéuticos Activos (API)
Fabricante de Principios Activos (API)Fabricante
Servicios de contratación y externalización
Proveedor de Síntesis a Medida
Mercados de Venta
- Western Europe: Austria, Belgium, France
- Northern America: Bermuda, Canada, Greenland, Saint Pierre and Miquelon, United States
- Central America: Belize, Costa Rica, El Salvador, Guatemala, Honduras, Mexico, Nicaragua, Panama
- South America: Argentina, Bolivia, Brazil, Chile, Colombia, Ecuador, Falkland Islands, French Guiana, Guyana, Paraguay, Peru, Suriname, Uruguay, Venezuela
Productos/Servicios Clave
- Ingredientes Farmacéuticos Activos (API): Antitumor API
- Servicios de contratación y externalización: Custom Synthesis
- Productos químicos, solventes y estándares de referencia de laboratorio: Impurity reference materials
- Químicos Farmacéuticos: Regorafenib, GEFITINIB, Pharmaceutical Intermediates, (R)-(+)-1-(1-Naphthyl)ethylamine, (S)-(-)-1-(1-naphthyl)ethylamine, Lenvatinib Mesylate, Sorafenib Tosylate, Abemaciclib, 3-[(Aminoiminomethyl)amino]-4-methylbenzoic acid ethyl ester mononitrate, Cinacalcet hydrochloride, 4'-chloro-5,5-diMethyl-3,4,5,6-tetrahydro-[1,1'-biphenyl]-2-carbaldehyde, 1H-Pyrrolo[2,3-b]pyridin-5-ol, 1-[tris(1-methylethyl)silyl]-, 3-nitro-4-((tetrahydro-2H-pyran-4-yl)MethylaMino)benzenesulfonaMide, Ibrutinib, 1-(3-Pyridyl)-3-(dimethylamino)-2-propen-1-one, 1-((4'-chloro-5,5-dimethyl-3,4,5,6-tetrahydro-[1,1'-biphenyl]-2-yl)methyl)piperazine, 1-((4'-chloro-5,5-dimethyl-3,4,5,6-tetrahydro-[1,1'-biphenyl]-2-yl)methyl)piperazine dihydrochloride, 1-bromo-3-nitro-5-(trifluoromethyl)-, 2-[(1H-Pyrrolo[2,3-b]pyridin-5-yl)oxy]-4-[4-[[2-(4-chlorophenyl)-4,4-dimethylcyclohex-1-enyl]methyl], 2-(2-Fluoro-4-iodoanilino)-3,4-difluorobenzoic Acid, 2-Amino-6-fluorobenzonitrile, 2-Ethyl-5-nitrobenzenamine, 2-Methyl-5-nitrobenzenesulfonamide, 2,3-dimethyl-2H-indazol-6-amine hydrochloride, 2,3-dimethyl-6-nitro-1H-indazole, 2,4-Dichloropyrimidine, (2E)-3-(Dimethylamino)-1-(3-pyridyl)prop-2-en-1-one, 3-[3-(Trifluoromethyl)phenyl]prop-2-enoic acid, 3-(3-Trifluoromethylphenyl)propionic acid, 3-(4-Methyl-1H-imidazol-1-yl)-5-(trifluoromethyl)aniline, 3-Amino-4-methylbenzoic acid ethyl ester, 3-Amino-5-bromobenzotrifluoride, 3-Methyl-6-nitro-1H-indazole, 4-(3-Chloro-4-fluorophenylamino)-7-methoxyquinazolin-6-ol, 4-(4-Amino-3-fluorophenoxy)pyridine-2-carboxylic acid methylamine, 4-(4-Aminophenoxy)-N- methylpicolinamide, 4-Amino-3-fluorophenol, 4-Chloropyridine-2- forMic acidMethyl ester, 4-Methyl-3-[[4-(3-pyridinyl)-2-pyrimidinyl]amino]benzoic acid, 5-Thiazolecarboxamide,2-amino-N-(2-chloro-6-methylphenyl)-, 5-Thiazolecarboxamide,N-(2-chloro-6-methylphenyl)-2-[(6-chloro-2-methyl-4-pyrimidinyl)amino]-, 6-Bromo-4-fluoro-1-isopropyl-2-methyl-1H-benzo[d]imidazole, ABT-199, Benzenesulfonamide,5-amino-2-methyl-, Benzoic acid,4-methyl-3-[[4-(3-pyridinyl)-2-pyrimidinyl]amino]-, ethyl ester, Cinacalcet, Dasatinib, Dasatinib Monohydrate, Formalin; Methanal, lenvatinib, methyl 2-(1H-pyrrolo[2,3-b]pyridin-5-yloxy)-4-fluorobenzoate, Methyl 3-amino-4-methylbenzoate, N-(2-chloropyriMidin-4-yl)-2,3-diMethyl-2H- indazol-6-aMine, N-(2-chloropyriMidin-4-yl)-N,2,3-triMethyl-2H-indazol-6-aMine, N-Methyl-4-chloropyridine-2-carboxamide, N-((R)-1-(naphthalen-1-yl)ethyl)-3-(3-(trifluoroMethyl)phenyl)propanaMide, Nilotinib, Nilotinib hydrochloride monohydrate, Nintedanib, Nintedanib Ethanesulfonate Salt, Pazopanib, Pazopanib hydrochloride, (R)-(+)-1-(1-Naphthyl)ethylamine hydrochloride, Regorafenib Hydrate, Regorafenib (Hydrochloride), Sorafenib
Nuestros Productos & Servicios
Sell · Pharma Chemicals
Sell · Pharma Chemicals
Sell · Pharma Chemicals
Sell · Pharma Chemicals
Sell · Pharma Chemicals
Sell · Pharma Chemicals
Sell · Pharma Chemicals
Calificaciones
(0)
(0)
(0)
(0)
(0)
Comentarios
Filtros:
Ordenar por:
No hay comentarios disponibles.
Deja tu valoración & comentario